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O B J E C T I V E S The purpose of this study was to compare the prognostic role of various computed
tomography (CT) signs of right ventricular (RV) dysfunction, including 3-dimensional ventricular volume
measurements, to predict adverse outcomes in patients with acute pulmonary embolism (PE).
B A C KG ROUND Three-dimensional ventricular volume measurements based on chest CT have
become feasible for routine clinical application; however, their prognostic role in patients with acute PE
has not been assessed.
METHOD S We evaluated 260 patients with acute PE for the following CT signs of RV dysfunction
obtained on routine chest CT: abnormal position of the interventricular septum, inferior vena cava
contrast reﬂux, right ventricle diameter (RVD) to left ventricle diameter (LVD) ratio on axial sections and
4-chamber (4-CH) views, and 3-dimensional right ventricle volume (RVV) to left ventricle volume (LVV)
ratio. Comorbidities and fatal and nonfatal adverse outcomes according to the MAPPET-3 (Management
Strategies and Prognosis in Pulmonary Embolism Trial-3) criteria within 30 days were recorded.
R E S U L T S Fifty-seven patients (21.9%) had adverse outcomes, including 20 patients (7.7%) who died
within 30 days. An RVDaxial/LVDaxial ratio 1.0 was not predictive for adverse outcomes. On multivariate
analysis (adjusting for comorbidities), abnormal position of the interventricular septum (hazard ratio [HR]:
2.07; p 0.007), inferior vena cava contrast reﬂux (HR: 2.57; p 0.001), RVD4-CH/LVD4-CH ratio1.0 (HR: 2.51;
p  0.009), and RVV/LVV ratio 1.2 (HR: 4.04; p  0.001) were predictive of adverse outcomes, whereas
RVD4-CH/LVD4-CH ratio1.0 (HR: 3.68; p 0.039) and RVV/LVV ratio1.2 (HR: 6.49; p 0.005) were predictive
of 30-day death.
CONC L U S I O N S Three-dimensional ventricular volume measurement on chest CT is a predictor of
early death in patients with acute PE, independent of clinical risk factors and comorbidities. Abnormal
position of the interventricular septum, inferior vena cava contrast reﬂux, and RVD4-CH/LVD4-CH ratio are
predictive of adverse outcomes, whereas RVDaxial/LVDaxial ratio 1.0 is not. (J Am Coll Cardiol Img
2011;4:841–9) © 2011 by the American College of Cardiology Foundation
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RVV right ventricular volu
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842ight ventricular (RV) failure is the most com-
mon cause of early death among patients
with acute pulmonary embolism (PE) (1–5).
While bedside echocardiography remains the
rst-line test for diagnosing RV dysfunction (3,5–
), chest computed tomography (CT) has become
he preferred imaging modality for PE diagnosis in
table patients, because it is accurate and available
4 h daily at most institutions (8,9). Several studies
ave evaluated chest CT signs for determining the
everity of RV dysfunction and for predicting pa-
ient outcome (10–31), including flattening or dis-
lacement of the interventricular septum toward the
eft ventricle, reflux of contrast material into the
nferior vena cava (IVC), and measurements of RV
iameter (RVD) divided by left ventricular diame-
ers (LVD) on transverse chest CT sections or
reconstructed 4-chamber (4-CH) views.
However, because the ventricles have a
complex 3-dimensional (3D) shape, 3D
assessment of right ventricular volume
(RVV) and left ventricular volume (LVV)
may be more useful as a surrogate marker
for RV dysfunction in patients with acute
PE. Image post-processing methods en-
abling 3D volumetry of the ventricles have
recently become available. A previous
study (15) demonstrated that ventricular
volume measurements at electrocardio-
gram (ECG)-gated chest CT were more
sensitive for identifying patients with pos-
sible RV dysfunction than diameter mea-
surements on non–ECG-gated chest CT.
However, routine ECG-gating of chest
CT studies for diagnosing PE is not cur-
rently recommended because of the addi-
tional radiation exposure involved with
CG-gated techniques (8,9) and because of the
nly limited incremental diagnostic improvement
ver routine non–ECG-gated chest CT (23).
Accordingly, the purpose of this current investi-
ation was to compare, in patients with acute PE,
he prognostic value for adverse outcomes and
0-day mortality of 3D volumetric ventricular anal-
sis based on routine, non–ECG-gated chest CT
ith all other described chest CT signs of RV
ysfunction.
M E T H O D S
Patient population. From April 2007 through Au-
gust 2009 we performed 1,606 contrast-enhanced
y
ter
e
mechest CT studies for suspected PE, and 302 of thesestudies were interpreted as positive for new onset,
acute PE. Of these, a total of 260 patients were
included in the present analysis after 36 patients
were excluded because of incomplete follow-up
during the study period. Six patients were excluded
because of insufficient contrast enhancement of the
ventricular chambers for reliable delineation of the
endocardial borders.
In all, 173 patients (66.5%) were inpatients
already hospitalized at the time of acute PE diag-
nosis. Primary reasons for hospitalization and com-
plications other than acute PE during the hospital
stay included major surgery in 93 patients, trauma
in 32, pneumonia in 29, stroke in 14, sepsis in 11,
major hemorrhage in 9, myocardial infarction in 2,
and multisystem organ failure in 1 patient.
For indicating imaging work-up of suspected PE,
our institution generally follows the recommenda-
tions as outlined by the Christopher Study Investi-
gators (32) and by Piazza et al. (33). All patients
included in this study were hemodynamically stable
and had undergone a clinical assessment of the
probability of PE, using the original Wells scoring
system (34). Our study population included 172
patients (66.2%) with a Wells score 4 and 88
patients (33.8%) with abnormal D-dimer test.
Adverse clinical outcomes. Adverse clinical out-
comes were defined as death within 30 days or
escalation of therapy, according to the MAPPET-3
(Management Strategies and Prognosis in Pulmo-
nary Embolism Trial-3) study criteria (4), including
cardiopulmonary resuscitation, endotracheal intu-
bation, vasopressors for systemic hypotension,
thrombolysis, or surgical embolectomy. Demo-
graphic information (age and sex) and medical
history (history of cancer, coronary artery disease,
congestive heart failure, diabetes mellitus, chronic
lung disease, and renal insufficiency) were recorded
on the basis of patients’ medical records.
Chest CT procedures. All patients had undergone
non–ECG-gated chest CT on a 64-slice
multidetector-row CT system (Somatom Sensation
64, Siemens, Forchheim, Germany). Image acqui-
sition parameters consisted of 0.6 mm collimation,
120 kV, 160 mAseff, pitch of 1.2, and a recon-
structed section thickness of 1 mm. Contrast me-
dium enhancement was achieved with 100 ml of a
nonionic iodinated contrast medium (Ultravist 370,
Bayer-Schering, Wayne, New Jersey) injected at 4
ml/s using a power injector (Stellant D, Medrad,
Indianola, Pennsylvania). Automated bolus trigger-A B B R E V I A T I O N S
A N D A C R O N YM S
AUC area under the curve
CI confidence interval
CT computed tomograph
ECG electrocardiogram
4-CH four-chamber
IVC inferior vena cava
LV left ventricle
LVD left ventricular diame
LVV left ventricular volum
PE pulmonary embolism
RV right ventricle
RVD right ventricular
diametering was used with a region of interest in the main
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843pulmonary artery and a threshold of 100 Hounsfield
units for initiating data acquisition.
Chest CT interpretation. In case of multiple CT
xaminations for serial follow-up, we included only
he first CT study performed at the time of the
nitial presentation. In a pilot investigation (21),
hest CT studies of 50 consecutive patients had
een independently reviewed by 2 experienced ob-
ervers (D.K.K., C.T.) for analysis of interobserver
ariability. The remaining 210 patients were evalu-
ted by 1 of the observers (D.K.K.). Observers were
linded to the patients’ clinical characteristics. All
T studies were reviewed and analyzed on a clinical
orkstation (MultiModality Workplace, Siemens).
SEPTAL BOWING. Deviation of the interventricular
eptum was evaluated as follows: normal (convex
oward the RV), flattened, and septal bowing (con-
ex toward the left ventricle) (25). Flattened septum
Fig. 1A) and septal bowing (Fig. 2A) were con-
idered abnormal positions of the septum indicating
V strain.
IVC REFLUX. The severity of reflux of contrast
medium into the IVC or hepatic veins was graded
according to a previously published scale (12):
Figure 1. Computed Tomography Signs of RV Dysfunction in a
(A) In a 77-year-old woman with acute pulmonary embolism, a 4-ch
scan shows septal ﬂattening (arrows). (B) There is also grade 4 reﬂu
proximal hepatic veins (short arrows). Measurements of (C) maxim
(LVD) on axial sections show RVD axial/LVD axial ratio of 0.98. Meas
RVD4-CH/LVD4-CH ratio of 1.12. Semiautomated right ventricle volum
played (G) on axial section and (H) on sagittal reformation shows R
the ﬁrst day of her hospital stay and died on day 28.1  no reflux; 2  trace of reflux into IVC only;
3  reflux into IVC but not hepatic veins; 4 
reflux into IVC and proximal hepatic veins; 5 
reflux into IVC and hepatic veins down to the
mid-portion of the liver; 6  reflux into IVC with
pacification of distal hepatic veins (Fig. 1B). The
egree of reflux was grouped into nonsubstantial
grades 1 to 3) and substantial (grades 4 to 6).
RVD/LVD RATIO. The 2 axial sections that showed
the maximal distance between the ventricular endo-
cardium and the interventricular septum, perpen-
dicular to the long axis of the heart, for the RV and
LV, respectively, were identified. RVDaxial and
LVDaxial were subsequently measured, and the
RVDaxial/LVDaxial ratio was calculated (Figs. 1 and 2).
ext, 4-CH views were reconstructed on the work-
tation using our previously described approach
21,26), and RVD4-CH/LVD4-CH ratios were
alculated.
RVV/LVV RATIO. The 3D volumetric analysis of
oth ventricles was performed by using the volume
nalysis application of the workstation (Volume
nalysis, Siemens). The endocardial contours were
emiautomatically segmented from the valvular
ear-Old Woman
ber (4-CH) view reconstruction of a chest computed tomography
f contrast medium into the inferior vena cava (long arrow) and
ht ventricular diameter (RVD) and (D) left ventricular diameter
ments of (E) maximal RVD and (F) LVD on 4-CH views show
(RVV) (purple) and left ventricle volumetry (LVV) (orange) dis-
VV ratio of 1.62. The patient required mechanical ventilation on77-Y
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844plane down to the apex of both ventricles. That
involved manually outlining the endocardial con-
tours on the transverse sections comprising the
minimal and maximal expanse of the ventricle,
which were then automatically propagated to the
neighboring sections. The RVV/LVV ratio was
subsequently calculated (Figs. 1 and 2). The time
eeded to perform the volumetric measurements
anged between 3.7 min and 10.9 min (21).
Statistical analysis. We used MedCalc (version
10.4.8, MedCalc Software, Mariakerke, Belgium)
for all statistical analyses. We used the chi-square
test or Fisher exact test for comparisons of categor-
ical variables and the Mann-Whitney test for com-
parisons in the distributions of continuous variables.
Using receiver-operator characteristic curves (in
accordance with the methods of DeLong et al.
[35]), the area under the curve (AUC) of RVDaxial/
LVDaxial, RVD4-CH/LVD4-CH, and RVV/LVV for
predicting adverse events and 30-day death were
compared, and optimal cutoff values, weighted for
higher sensitivity, for the above ratios were as-
signed, similar to previous investigations (26,28);
these cutoffs were used for subsequent analyses. The
Figure 2. Computed Tomography Signs of RV Dysfunction in a
(A) In a 69-year-old man with acute pulmonary embolism, a 4-cham
scan shows septal bowing (arrows), convex toward the left ventricl
ments of (C) maximal right ventricular diameter (RVD) and (D) left v
ratio of 0.97. Measurements of maximal (E) RVD and (F) LVD on 4-C
tricle volumetry (RVV) (purple) and left ventricle volumetry (LVV) (o
mation show an RVV/LVV ratio of 1.54. The patient died on hospitaCox proportional hazard model was used to calcu- tlate the hazard ratio of clinical variables and CT
measurements for predicting adverse outcomes.
Multivariate analysis was then performed to iden-
tify predictors of adverse outcomes, using the pro-
portional hazards model with calculation of 95%
confidence intervals (CIs). Each CT sign was eval-
uated in a separate model accounting for clinical
characteristics and comorbidities that were signifi-
cant (p  0.05) predictors of adverse outcomes and
30-day death.
R E S U L T S
Clinical characteristics of study population. The mean
age of the patient population was 55  18 years,
nd there were 139 (53.5%) men. In all patients, the
nitial clinical diagnosis of PE was confirmed by the
resence of at least 1 filling defect in the pulmonary
rtery tree (8,9). One hundred forty-five patients
71.4%) had relevant comorbidities, including can-
er in 59, coronary artery disease in 35, congestive
eart failure in 13, diabetes mellitus in 40, chronic
nterstitial lung disease in 26, and renal insufficiency
n 36. There were no statistical differences between
ear-Old Man
(4-CH) view reconstruction of a chest computed tomography
) There is no contrast reﬂux into the inferior vena cava. Measure-
ricular diameter (LVD) on axial sections show RVDaxial/LVDaxial
iews show RVD4-CH/LVD4-CH ratio of 1.4. Semiautomated right ven-
e) displayed (G) on transverse section and (H) on coronal refor-
y 4.69-Y
ber
e. (B
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845cluded patients and final study population (p 0.05
for all measures).
Fifty-seven patients (21.9%) had adverse clin-
ical outcomes, including 20 (7.7%) who died
within 30 days. Of the 37 (14.2%) surviving
patients with adverse outcomes, 35 required en-
dotracheal intubations, 15 were treated with va-
sopressors, 11 received thrombolysis, 7 required
cardiopulmonary resuscitation, and 4 underwent
surgical embolectomy. Adverse outcomes oc-
curred in the range from 1 day to 30 days (mean
10.4  9.6 days) from the time of diagnosis.
atients with adverse outcomes were older and
ore commonly had diabetes mellitus, renal in-
ufficiency, and sepsis (Table 1), whereas cancer,
iabetes mellitus, renal insufficiency, and sepsis
ere more common among patients who died
ithin 30 days (Table 2); these parameters were
ubsequently included in the relevant multivariate
nalyses.
Interobserver reproducibility. The pilot investigation
21) in 50 patients had shown fair interobserver
eproducibility for describing the position of the
entricular septum (k  0.32), with moderate
eproducibility (k  0.44) for differentiating
ormal versus abnormal (i.e., flattening or bow-
ng) position. There was good agreement (k 
.68) for classifying the degree of contrast me-
ium reflux into the IVC and hepatic veins as
onsubstantial versus substantial. Correlation co-
fficients for measurements of RVDaxial/LVDaxial
ratio, RVD4-CH/LVD4-CH ratio, and RVV/LVV
ratio measurements between the 2 observers were
0.88, 0.85, and 0.93 respectively (p  0.001 for
all correlations).
Prognostic value of CT signs. There were no differ-
ences in the AUC of RVDaxial/LVDaxial, RVD4-CH/
LVD4-CH, and RVV/LVV with AUCs of 0.658
(95% CI: 0.597 to 0.715), 0.659 (95% CI: 0.598 to
0.717), and 0.677 (95% CI: 0.617 to 0.734), respec-
tively, for predicting adverse events (p  0.565 to
0.940); and AUCs of 0.698 (95% CI: 0.638 to
0.753), 0.694 (95% CI: 0.634 to 0.750), and 0.664
(95% CI: 0.603 to 0.721), respectively, for predict-
ing 30-day death (p  0.603 to 0.937). Receiver-
operator characteristic analysis identified RVDaxial/
VDaxial 1.0, RVD4-CH/LVD4-CH 1.0, and
RVV/LVV 1.2 as optimal cutoffs with high
sensitivity (70%) for predicting 30-day death;
these values were used for subsequent analyses.
Table 3 illustrates the prevalence of the measured
CT signs in patients with and without adverse
events and 30-day death. The sensitivities andspecificities of CT signs for predicting adverse
outcomes and 30-day death are presented in
Table 4.
Table 1. Clinical Characteristics and Comorbidities in Patients W
Adverse Outcomes
Adverse Outcome
(n  57)
No Adverse Ou
(n  203
Age, yrs, mean  SD 59 16 54 18
Men 34 (59.6%) 105 (51.7%
Within 30 days before PE
diagnosis
Major surgery 19 (33.3%) 74 (36.5%
Pneumonia 10 (17.5%) 19 (9.4%)
Sepsis 8 (14.0%) 3 (1.5%)
Trauma 9 (15.8%) 23 (11.3%
Stroke 4 (7.0%) 10 (4.9%)
Major hemorrhage 2 (3.5%) 7 (3.4%)
Myocardial infarction 1 (1.8%) 1 (0.5%)
Multisystem organ failure 1 (1.8%) 0 (0.0%)
Comorbidities
Cancer 15 (26.3%) 44 (21.7%
Coronary artery disease 9 (15.8%) 26 (12.8%
Congestive heart failure 4 (7.0%) 9 (4.4%)
Diabetes mellitus 14 (24.6%) 26 (12.8%
Chronic lung disease 5 (8.8%) 21 (10.3%
Renal insufﬁciency 20 (35.1%) 16 (7.9%)
*Statistically signiﬁcant p value.
PE  pulmonary embolism.
Table 2. Clinical Characteristics and Comorbidities of Patients W
Patients Who Survived
Death
(n  20)
Surviva
(n  24
Age, yrs, mean  SD 61 15 54 1
Men 15 (75.0%) 124 (51.7
Within 30 days before PE diagnosis
Major surgery 6 (30.0%) 87 (36.3
Pneumonia 4 (20.0%) 25 (10.4
Sepsis 5 (25.0%) 6 (2.5%
Trauma 1 (5.0%) 31 (12.9
Stroke 0 (0.0%) 14 (5.8%
Major hemorrhage 1 (5.0%) 8 (3.3%
Myocardial infarction 1 (5.0%) 1 (0.4%
Multisystem organ failure 1 (5.0%) 0 (0.0%
Comorbidities
Cancer 9 (45.0%) 50 (20.8
Coronary artery disease 4 (20.0%) 31 (12.9
Congestive heart failure 3 (15.0%) 10 (4.2%
Diabetes mellitus 7 (35.0%) 33 (13.8
Chronic lung disease 3 (15.0%) 23 (9.6%
Renal insufﬁciency 12 (60.0%) 24 (10.0
*Statistically signiﬁcant p value.ith and Without
tcome
) p Value
0.021*
) 0.298
) 0.755
0.096
0.001*
) 0.366
0.515
1.000
0.391
0.219
) 0.477
) 0.519
0.490
) 0.038*
) 1.000
0.001*ho Died Versus
l
0) p Value
7 0.064
%) 0.061
%) 0.636
%) 0.255
) 0.001*
%) 0.484
) 0.610
) 0.519
) 0.148
) 0.077
%) 0.023*
%) 0.324
) 0.068
%) 0.020*
) 0.433
%) 0.001*PE  pulmonary embolism.
a
o
right ventricular volume.
Abbreviations as in
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846Multivariate analysis demonstrated that RVDaxial/
LVDaxial 1.0 was not independently predictive of
adverse outcomes or 30-day death. Abnormal po-
sition of the interventricular septum, substantial
IVC contrast reflux, RVD4-CH/LVD4-CH 1.0,
nd RVV/LVV 1.2 were independent predictors
f adverse events, while RVD4-CH/LVD4-CH 1.0
and RVV/LVV were predictive of 30-day death,
with hazard ratios of 3.68 (95% CI: 1.08 to 12.60;
p  0.039) and 6.49 (95% CI: 1.77 to 23.84; p 
0.005), respectively (Table 5). Among 149 patients
with RVV/LVV ratio 1.2, 45 had adverse events
within 30 days (representing a positive predictive
omography Signs of Right Ventricular Dysfunction for
utcomes and 30-Day Death
nction
Adverse Outcomes
(n  57)
No Adverse Outcomes
(n  203)
p ValueDeath (n  20) Survival (n  240)
eptum 29 (50.9%) 62 (30.5%) 0.014*
9 (45.0%) 82 (34.2%) 0.338
22 (38.6%) 29 (14.3%) 0.001*
5 (25.0%) 46 (19.2%) 0.558
36 (63.2%) 112 (55.2%) 0.355
15 (75.0%) 133 (55.4%) 0.104
45 (78.9%) 117 (57.6%) 0.006*
17 (85.0%) 145 (60.4%) 0.031*
45 (78.9%) 104 (51.2%) 0.001*
17 (85.0%) 132 (55.0%) 0.009*
raphy; 4-CH  4-channel; IVC  inferior vena cava; LVD  left ventricular
icular volume; RV  right ventricular; RVD  right ventricular diameter; RVV 
ty and Speciﬁcity Values of CT Signs for Predicting
and 30-Day Death
Dysfunction Sensitivity Speciﬁcity
of septum
dverse outcomes 50.9% (29/57) 69.5% (141/203)
0-day death 45% (9/20) 65.8% (158/240)
dverse outcomes 38.6% (22/57) 85.7% (174/203)
0-day death 25.0% (5/20) 80.8% (194/240)
1.0
dverse outcomes 63.2% (36/57) 44.8% (91/203)
0-day death 75% (15/20) 44.6% (107/240)
1.0
dverse outcomes 78.9% (45/57) 42.4% (86/203)
0-day death 85.0% (17/20) 39.6% (95/240)
dverse outcomes 78.9% (45/57) 48.8% (99/203)
0-day death 85.0% (17/20) 45.0% (108/240)Table 3.value of 30.2%), and 17 died (positive predictive
value of 11.4%). Among 111 patients with RVV/
LVV 1.2, 99 experienced no adverse events (neg-
ative predictive value 89.2%) and 108 survived
(negative predictive value 97.3%).
D I S C U S S I O N
We show that 3D measurement of ventricular
volumes is superior to other chest CT signs of RV
dysfunction for predicting adverse outcomes and
30-day death in patients with acute PE. In our
cohort, among 149 patients with RVV/LVV ratio
1.2, 45 (30.2%) had adverse events within 30
days, and the risk of death within 30 days increased
approximately 6-fold. Conversely, in the absence of
an RVV/LVV ratio 1.2, most patients (97.3%)
survived. The routine availability of contemporary
advanced image post-processing workstations,
which automatically propagate the segmentation of
cardiac chambers, has greatly facilitated the perfor-
mance of 3D ventricular volume measurement.
Performing 3D volumetric ventricular measure-
ments can be accomplished on most current image
post-processing platforms. This evaluation method
may more appropriately account for the complex
shape of the cardiac ventricles than a single image
or plane.
In our cohort, the mortality rate was 7.7% within
30 days, and thus was very similar to the mortality
rates in other studies (3,5,36,37). The proportion of
patients who had nonfatal in-hospital adverse
events or required escalation of therapy was similar
to that in the MAPPET-3 study (4). The patients
enrolled in our study suffered from a variety of
severe diseases and may therefore have died of other
reasons than PE. However, although, overall, most
deaths in PE patients occur because of pre-existing
underlying disease (37), the main cause of early
death, namely, within 30 days as in our study, is
acute RV failure (1,3).
The interventricular septum, which normally
bows toward the RV, may shift toward the LV
related to increased right-side heart pressure with
severe pulmonary arterial obstruction (16). Several
studies reported that ventricular septal bowing in-
dicated severe PE (13,25) as manifested by RV
dysfunction (14,20,22) and predicted short-term
death (10). Conversely, Araoz et al. (11), Van der
Meer et al. (31), Ghaye et al. (17), and Aviram et al.
(12) did not find this sign to be predictive of death
from acute PE. These latter findings correspond toTable 3. Computed T
Predicting Adverse O
CT Sign of RV Dysfu
Abnormal position of s
IVC contrast reﬂux
RVDaxial/LVDaxial 1.0
RVD4-CH/LVD4-CH 1.0
RVV/LVV 1.2
Values are n (%).
CT  computed tomog
diameter; LVV  left ventrTable 4. Sensitivi
Adverse Outcome
CT Sign of RV
Abnormal position
For predicting a
For predicting 3
IVC contrast reﬂux
For predicting a
For predicting 3
RVDaxial/LVDaxial 
For predicting a
For predicting 3
RVD4-CH/LVD4-CH 
For predicting a
For predicting 3
RVV/LVV 1.2
For predicting a
For predicting 3
Values are % (n/N).our current results, where abnormal position of the
L
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847interventricular septum was overall predictive of
adverse events but not of 30-day death.
Reflux of contrast medium into the IVC is an
indirect sign of increased RV pressure and can be
seen in various underlying conditions (21). While
substantial IVC reflux was predictive of adverse
outcomes in our study, it failed to identify patients
at risk of early death. Increased RVD/LVD ratio on
chest CT has been proposed as a sign of RV
dysfunction. However, multiple quantitative meth-
ods and cutoff points have been described to assess
dilatation of the complex-shaped RV in patients
with acute PE. Araoz et al. (10) and Contractor et
al. (14) measured both ventricles at the level of the
atrioventricular valves, whereas van der Meer et al.
(31) used maximum minor axis measurements.
Contractor et al. (14) and Lim et al. (22) found a
RVDaxial/LVDaxial ratio of 1 as measured on
transverse sections indicative of severe PE, while
others proposed a threshold of 1.5 (13,27). Sev-
eral studies report that an increased RVDaxial/
VDaxial ratio on transverse chest CT sections
ndicates RV dysfunction (14,20,22) and predicts
hort-term death (10), although others found this
ign not to be associated with increased mortality in
table patients without shock (29).
Although a recent report (30) described no sta-
istically significant difference between measure-
ents of RV enlargement on axial and 4-CH views,
ogan et al. (15) reported significant differences for
VD4-CH/LVD4-CH ratios between patients with
nd without PE but not for RVDaxial/LVDaxial
ratios on transverse sections. These findings corre-
spond to our own prior investigations (26,28),
where we found that the proportion of patients with
increased RVDaxial/LVDaxial ratios on transverse
ections was similar for patients with and without
dverse events. However, ventricular measurements
n 4-CH views were superior, with an AUC of
.753 of RVD4-CH/LVD4-CH0.9 versus an AUC
f 0.667 of RVDaxial/LVDaxial 0.9, for predicting
dverse outcomes. In our current investigation,
lthough RVDaxial/LVDaxial 1.0 was more com-
mon in patients who died within 30 days, this param-
eter was neither predictive of adverse outcomes overall
nor of early death. Compared with our previous
studies (26,28), receiver-operator characteristic analy-
sis in our current investigation revealed a slightly
higher RVD4-CH/LVD4-CH ratio cutoff (1.0 vs. 0.9),
which, however, is identical to the RVD/LVD cutoff
of 1.0 used in the MAPPET-2 trial (3) and the
PIOPED (Prospective Investigation of Pulmonary
Embolism Diagnosis) II study (38).Study limitations. The most important limitation of
our study is its retrospective nature. Also, we did
not include patients without PE as a control
group to determine whether these findings are
unique to PE positive patients. However, our
current investigation is 1 of the largest analyses to
date evaluating the prognostic value of chest CT
signs of RV dysfunction in patients with acute
PE. It is the only study systematically comparing
all signs that have been described for this pur-
pose, including the rather recent method of 3D
ventricular volumetry. Our study would have
been strengthened by correlation with echocardi-
ography findings; unfortunately, only a small
percentage of our patients (100 of 260, 38.5%)
had echocardiography findings available. Consid-
ering that prior studies have established a good
correlation between echocardiography and CT
findings (18,20,22,24,26), we chose not to for-
mally analyze this small subset of our patients.
Another potential limitation of our present
study is that chest CT image acquisition was not
ECG gated. Non–ECG-gated CT is inevitably
inaccurate for measuring ventricular chamber
size, because the images are acquired in different
phases of the cardiac cycle. However, the use of
ECG-gated CT protocols over routine chest CT
has been shown to result in only limited incre-
Table 5. Multivariate Analysis of CT Signs for Predicting Advers
and 30-Day Death
CT Sign of RV Dysfunction n
Multivaria
HR 95%
Abnormal position of septum
For predicting adverse outcomes 29 2.0726 1.2216–
For predicting 30-day death 9 2.3919 0.9349–
IVC contrast reﬂux
For predicting adverse outcomes 22 2.5718 1.4688–
For predicting 30-day death 5 1.8337 0.6361–
RVDaxial/LVDaxial 1.0
For predicting adverse outcomes 36 1.4158 0.7948–
For predicting 30-day death 15 2.0848 0.7325–
RVD4-CH/LVD4-CH 1.0
For predicting adverse outcomes 45 2.5084 1.2622–
For predicting 30-day death 17 3.6839 1.0771–
RVV/LVV 1.2
For predicting adverse outcomes 45 4.0379 1.9970–
For predicting 30-day death 17 6.4919 1.7678–
Age, diabetes mellitus, renal insufﬁciency, and sepsis were statistically signiﬁcan
adverse events and subsequently included in the relevant multivariate analysis.
renal insufﬁciency, and sepsis were statistically signiﬁcant (p  0.05) predict
included in the relevant multivariate analysis. *Statistically signiﬁcant p value.
CI  conﬁdence interval; HR  hazard ratio; other abbreviations as in Table 3e Outcomes
te Analysis
CI p Value
3.5164 0.007*
6.1192 0.070
4.5032 0.001*
5.2864 0.264
2.5221 0.240
5.9339 0.171
4.9850 0.009*
12.5994 0.039*
8.1646 0.001*
23.8402 0.005*
t (p  0.05) predictors of
Cancer, diabetes mellitus,
ors of 30-day death andmental diagnostic improvements (23). More im-
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848portantly, because of the additional radiation
exposure involved with ECG-gated techniques,
this approach is not currently used for routine PE
imaging (8), whereas our results obtained in
non–ECG-gated chest CT studies are directly
transferable to clinical practice. Finally, the clin-
ical applicability of our results is limited by
interobserver variability and 3D workstation re-
quirements; however, we believe continuing evo-
lution and implementation of CT technology
should mitigate this limitation in the future.
C O N C L U S I O N S
In conclusion, we show that abnormal position ofraphy for diagnosis of pulmonary em-
1
1
1
1
1
1
78–84.and RVD4-CH/LVD4-CH ratio are predictive of
dverse outcomes. However, 3D measurement of
entricular volumes is superior to all other chest CT
igns of RV dysfunction for predicting adverse
utcomes and 30-day death in patients with acute
E. Future studies are needed to investigate the
enefit of cardiac volumetric measurements for
rospectively guiding patient management in com-
arison to and in combination with other risk
ssessment tools, such as echocardiography or car-
iac biomarkers (39–43).
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